The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total CDK9 assay is a sandwich immunoassay for quantitative detection of total CDK9 in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 30 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total CDK9 assay is a sandwich immunoassay for quantitative detection of total CDK9 in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Cyclin dependent kinase 9 (CDK9) is a member of the CDK family. CDK9 was found to be a component of the multiprotein complex TAK/P-TEFb which regulates transcription elongation through phosphorylation of the C-terminal tail domain (CTD) of RNA polymerase II (RNAP II). This crucial function combined with evidence that transcriptional programs are dysregulated in cancer make CDK9 an attractive target for cancer therapies.
The AlphaLISA SureFire Human and Mouse Total CDK9 Detection Kit is a sandwich immunoassay for the quantitative detection of total CDK9 in cellular lysates, using Alpha Technology.
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
30 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
CDK9
|
Target Class |
Phosphoproteins
|
Target Species |
Human
Mouse
|
Technology |
Alpha
|
Therapeutic Area |
Oncology
|
Unit Size |
100 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
CDK9 is an attractive target for cancer therapeutics due to its crucial role in transcription regulation, particularly of short...
Therapeutic antibodies directed to cell surface receptors are increasingly being developed as treatments for a variety of diseases...
The measurement of protein phosphorylation is a useful tool for measuring the modulation of receptor activation by both antibodies...
We are here to answer your questions.